Management of antithrombotic therapy after prosthetic valve implantation

dc.authorscopusid55694390400
dc.authorscopusid57190186963
dc.authorscopusid24773439000
dc.authorscopusid35581189900
dc.contributor.authorKalçık, Macit
dc.contributor.authorGüner, Ahmet
dc.contributor.authorGündüz, Sabahattin
dc.contributor.authorÖzkan, Mehmet
dc.date.accessioned2021-11-01T14:51:34Z
dc.date.available2021-11-01T14:51:34Z
dc.date.issued2021
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractTo the Editor, We have recently read with great interest the article by Wei et al. entitled “Recurrent prosthetic valve dysfunction in a patient with idiopathic hypereosinophilic syndrome: A case report and literature review”1 We appreciate the authors for the management of therapy in a patient with recurrent prosthetic valve dysfunction. On the other hand, we believe that there are some major drawbacks that need to be addressed.
dc.identifier.citationKalçık, M., Güner, A., Gündüz, S., & Özkan, M. (2021). Management of antithrombotic therapy after prosthetic valve implantation. Journal of Cardiac Surgery.
dc.identifier.doi10.1111/jocs.16101
dc.identifier.issn0886-0440
dc.identifier.scopus2-s2.0-85117320228
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1111/jocs.16101
dc.identifier.urihttps://hdl.handle.net/11491/6185
dc.identifier.wosWOS:000708986200001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthorKalçık, Macit
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofJournal of Cardiac Surgery
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAntithrombotic Therapyen_US
dc.subjectPannusen_US
dc.subjectProsthetic Heart Valvesen_US
dc.subjectThrombusen_US
dc.titleManagement of antithrombotic therapy after prosthetic valve implantation
dc.typeLetter

Dosyalar